01 1Extrovis AG
01 1DIBASIC POTASSIUM PHOSPHATE
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-04-04
Pay. Date : 2025-03-07
DMF Number : 38688
Submission : 2023-08-04
Status : Active
Type : II
20
Extrovis Ag, based in Switzerland, is a pharmaceutical company.
They are recognized for Extrovis's success lies in improving healthcare through innovation.
One of their notable products is DIBASIC POTASSIUM PHOSPHATE, with a corresponding US DMF Number 38688.
Remarkably, this DMF maintains an Active status since its submission on August 04, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 04, 2025, and payment made on March 07, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
